Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with PsoriasisMario Gaio, Maria Giovanna Vastarella, Maria Giuseppa Sullo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 21, 2023
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?Annamaria Mascolo, Liberata Sportiello, Concetta Rafaniello, et al.
Frontiers in Pharmacology|September 21, 2018
Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern ItalyCristina Scavone, Concetta Rafaniello, Simona Brusco, et al.
British Journal of Pharmacology|April 25, 2020
Current pharmacological treatments for COVID-19: What's next?Cristina Scavone, Simona Brusco, Michele Bertini, et al.
Expert Opinion on Drug Safety|March 26, 2019
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern ItalyCristina Scavone, Cristina Di Mauro, Simona Brusco, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO StudyGabriella di Mauro, Annamaria Mascolo, Mario Gaio, et al.
Frontiers in Allergy|April 7, 2022
Pharmacological, Technological, and Digital Innovative Aspects in RhinologyRosanna Ruggiero, Giovanni Motta, Giuseppe Massaro, et al.
Frontiers in Immunology|September 30, 2022
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database EudravigilanceRosanna Ruggiero, Nunzia Balzano, Raffaella Di Napoli, et al.
Drug Safety|December 22, 2020
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance DatabaseGabriella di Mauro, Alessia Zinzi, Cristina Scavone, et al.
Frontiers in Psychiatry|December 21, 2020
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance DatabaseConcetta Rafaniello, Maria Giuseppa Sullo, Carla Carnovale, et al.
Pageof 10